Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate
Health Innovation Reports · 2025
DOI: 10.64048/hir.v1n2.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Innovation Reports, 2025. Verfasst von Farzand Farhad Hamid Hamid. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epigenetic modifications, including DNA methylation, histone modification, and non-coding RNAs, play crucial roles in regulating gene expression without altering the underlying DNA sequence. In cancer, these epigenetic processes are often disrupted, contributing to tumor initiation, growth, metastasis, and drug resistance. This article reviews the latest findings on epigenetic dysregulation in cancer, emphasizing how these modifications influence tumor behavior and presenting novel therapeutic strategies aimed at targeting the epigenome. Additionally, we explore the potential for integrating epigenetic biomarkers into precision oncology to enhance patient outcomes, with a focus on recent advancements from 2022 to 2025.
Zitieren
APA
Hamid, F. F. H. (2025). Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate. Health Innovation Reports. https://doi.org/10.64048/hir.v1n2.007
Vancouver
Hamid FFH. Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate. Health Innovation Reports. 2025. doi:10.64048/hir.v1n2.007
BibTeX
@article{Hamid2025,
author = {Hamid, Farzand Farhad Hamid},
title = {Epigenetic Dysregulation and Cancer Progression: How Epigenetic Modifications Shape Tumor Fate},
journal = {Health Innovation Reports},
year = {2025},
doi = {10.64048/hir.v1n2.007}
}
EUVIMED